129 related articles for article (PubMed ID: 9824909)
1. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
Reifart N; Störger H; Schwarz F; Rabe A
Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
[No Abstract] [Full Text] [Related]
2. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent.
Ho PC; Leung CY
J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363
[TBL] [Abstract][Full Text] [Related]
3. Elective Wiktor GX stenting for symptomatic stenosis in old aortocoronary saphenous vein bypass grafts: the Antwerp experience.
Van Langenhove G; Vermeersch P; Kay IP; Vaerenberg M; Heuten H; Stockman D; Convens C; Albertal M; Vrints C; Van den Branden F; Van den Heuvel P
J Invasive Cardiol; 1999 May; 11(5):274-80. PubMed ID: 10745530
[TBL] [Abstract][Full Text] [Related]
4. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
[TBL] [Abstract][Full Text] [Related]
5. Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
Van Langenhove G; Vermeersch P; Serrano P; Kutryk MJ; Stockman D; Convens C; Van den Branden F; Vanagt E; Albertal M; Van den Heuvel P
Can J Cardiol; 2000 Apr; 16(4):473-80. PubMed ID: 10787462
[TBL] [Abstract][Full Text] [Related]
6. [Postoperative percutaneous coronary angioplasty for stenosed aortocoronary vein bypass].
Otake H; Tanaka N; Mukai K; Fujii S; Michishita I; Shibazaki Y; Genda A; Iwa T
Kyobu Geka; 1991 Oct; 44(11):900-5. PubMed ID: 1942680
[TBL] [Abstract][Full Text] [Related]
7. Revitalizing embolic protection in saphenous vein grafts.
Satler LF
Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
[No Abstract] [Full Text] [Related]
8. Percutaneous intervention over the origin of a saphenous vein graft anastomosed with the St. Jude Medical Symmetry Aortic Connector System.
Fuertes J; Lozano I; Turiel JM; Llosa JC; Suarez E; de la Tassa CM
Catheter Cardiovasc Interv; 2004 Jan; 61(1):103-6. PubMed ID: 14696167
[TBL] [Abstract][Full Text] [Related]
9. Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
Kurowski V; Toelg R; Jain D; Richter C; Wiegand UK; Richardt G; Khattab AA
Am J Cardiol; 2005 Sep; 96(5):681-4. PubMed ID: 16125495
[TBL] [Abstract][Full Text] [Related]
10. Arterial versus venous bypass grafts in patients with in-stent restenosis.
Gaudino M; Cellini C; Pragliola C; Trani C; Burzotta F; Schiavoni G; Nasso G; Possati G
Circulation; 2005 Aug; 112(9 Suppl):I265-9. PubMed ID: 16159829
[TBL] [Abstract][Full Text] [Related]
11. Beyond embolic protection for saphenous vein graft disease.
Satler LF
Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
[No Abstract] [Full Text] [Related]
12. Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?
Fiorina C; Meliga E; Chizzola G; Curello S; Tayeh O; Vizzardi E; Dei Cas L; Ettori F
EuroIntervention; 2010 Sep; 6(4):461-6. PubMed ID: 20884433
[TBL] [Abstract][Full Text] [Related]
13. Vessel diameter should be taken into account in saphenous stenting.
Lozano I; Rondan J; Avanzas P
EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787
[No Abstract] [Full Text] [Related]
14. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem.
de Feyter PJ
Circulation; 2003 May; 107(18):2284-6. PubMed ID: 12742967
[No Abstract] [Full Text] [Related]
15. Coronary angioplasty and new devices in patients with prior coronary artery bypass graft surgery.
Ribeiro PA
Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I105-11. PubMed ID: 10191682
[No Abstract] [Full Text] [Related]
16. Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
Toutouzas K; Takagi T; Colombo A
J Invasive Cardiol; 2003 Dec; 15(12):722-4. PubMed ID: 14660828
[No Abstract] [Full Text] [Related]
17. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
[TBL] [Abstract][Full Text] [Related]
18. Expanded PTFE-grafts--should they be used for myocardial revascularization?
Fraedrich G; Hehrlein FW; Heinrich D; Scheld HH; Höge R
Life Support Syst; 1983; 1 Suppl 1():400-2. PubMed ID: 6336584
[No Abstract] [Full Text] [Related]
19. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
Bansal D; Sachdeva R; Mehta JL
J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
[No Abstract] [Full Text] [Related]
20. Optimal therapy for degenerated saphenous vein graft disease.
Kramer B
J Invasive Cardiol; 1995; 7 Suppl D():14D-20D. PubMed ID: 10155126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
